Aurinia Pharmaceuticals Inc (AUPH) — Cash Flow-to-Debt Ratio
Aurinia Pharmaceuticals Inc (AUPH) has a Cash Flow-to-Debt Ratio of 0.21x as of March 2026, meaning its operating cash flow of $32.56 Million could theoretically repay 0% of its total liabilities ($156.37 Million) in one year. See Aurinia Pharmaceuticals Inc (AUPH) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aurinia Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Aurinia Pharmaceuticals Inc across 28 annual periods. Also explore net asset momentum of Aurinia Pharmaceuticals Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Aurinia Pharmaceuticals Inc (1998–2025)
Year-by-year debt coverage analysis for Aurinia Pharmaceuticals Inc. For market capitalisation and broader financial context, see AUPH market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.80x | $135.66 Million | $170.26 Million | ▲ +210.8% |
| 2024 | 0.26x | $44.39 Million | $173.17 Million | ▲ +230.3% |
| 2023 | -0.20x | $-33.46 Million | $170.11 Million | ▲ +83.8% |
| 2022 | -1.22x | $-79.53 Million | $65.42 Million | ▲ +50.5% |
| 2021 | -2.45x | $-157.69 Million | $64.28 Million | ▼ -96.4% |
| 2020 | -1.25x | $-69.86 Million | $55.91 Million | ▲ +49.5% |
| 2019 | -2.47x | $-63.59 Million | $25.70 Million | ▼ -59.6% |
| 2018 | -1.55x | $-51.61 Million | $33.29 Million | ▲ +9.2% |
| 2017 | -1.71x | $-41.17 Million | $24.10 Million | ▼ -92.1% |
| 2016 | -0.89x | $-18.71 Million | $21.05 Million | ▲ +31.9% |
| 2015 | -1.31x | $-17.77 Million | $13.60 Million | ▲ +43.8% |
| 2014 | -2.32x | $-16.90 Million | $7.27 Million | ▼ -405.8% |
| 2013 | -0.46x | $-4.52 Million | $9.84 Million | ▲ +55.9% |
| 2012 | -1.04x | $-6.55 Million | $6.28 Million | ▼ -508.5% |
| 2011 | -0.17x | $-1.36 Million | $7.91 Million | ▲ +84.5% |
| 2010 | -1.10x | $-4.34 Million | $3.93 Million | ▲ +50.0% |
| 2009 | -2.21x | $-10.46 Million | $4.74 Million | ▼ -138.4% |
| 2008 | -0.93x | $-17.39 Million | $18.79 Million | ▲ +53.6% |
| 2007 | -2.00x | $-28.46 Million | $14.25 Million | ▲ +0.6% |
| 2006 | -2.01x | $-21.03 Million | $10.47 Million | ▼ -13.5% |
| 2005 | -1.77x | $-21.23 Million | $11.99 Million | ▲ +21.2% |
| 2004 | -2.25x | $-20.15 Million | $8.97 Million | ▼ -157.7% |
| 2003 | -0.87x | $-5.13 Million | $5.89 Million | ▼ -220.0% |
| 2002 | -0.27x | $-849.90K | $3.12 Million | ▲ +93.3% |
| 2001 | -4.07x | $-7.25 Million | $1.78 Million | ▲ +14.6% |
| 2000 | -4.77x | $-5.77 Million | $1.21 Million | ▼ -233.7% |
| 1999 | -1.43x | $-1.36 Million | $950.74K | ▼ -95.8% |
| 1998 | -0.73x | $-1.76 Million | $2.41 Million | — |